Therapeutic hub
Cardiovascular Peptides
Natriuretic peptide biology underpins both diagnostics and therapeutics, with a development history that illustrates how hard cardiovascular endpoints are to move.
Regulatory picture
Established diagnostic use; therapeutic development is mixed and instructive.
What this area covers
Natriuretic peptides regulate vascular tone, sodium handling, and fluid balance. Their measurement is a routine part of heart failure diagnosis, and their pharmacology has been targeted therapeutically for decades.
Several peptide-based cardiovascular programmes have failed to demonstrate outcome benefit despite favourable biomarker effects — a useful reminder that mechanism does not guarantee results.
Fig. 02 / Molecular pathwayWhere the field is now
Current interest includes peptide approaches to lipid modification and blood pressure regulation, plus cardiometabolic effects observed in incretin trials. Evidence quality varies sharply by programme and stage.
Editorial disclaimer
This site is educational and does not provide medical advice, dosing protocols, or treatment recommendations. Regulatory status and evidence strength differ sharply between compounds. A “research use only” label does not indicate that a product is appropriate for human use. Decisions about medicines belong with a qualified clinician.